GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
1.745
-0.175 (-9.11%)
At close: Dec 20, 2024, 4:00 PM
1.900
+0.155 (8.88%)
After-hours: Dec 20, 2024, 6:45 PM EST
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $3.90 million as of December 20, 2024. Its market cap has decreased by -60.46% in one year.
Market Cap
3.90M
Enterprise Value
-2.52M
1-Year Change
-60.46%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $3.90M, a decrease of -99.58%. That is a compound annual growth rate of -12.46%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 4.91M |
| Biomerica | 4.90M |
| Predictive Oncology | 4.87M |
| Healthcare Triangle | 4.86M |
| Clearmind Medicine | 4.66M |
| NewGenIvf Group | 4.47M |
| Galmed Pharmaceuticals | 4.37M |
| Protagenic Therapeutics | 4.36M |